I do not know if I should be laughing or crying. Well at least Dmab "advanced" at a 147% clip (or is it clop?). If our pipeline scores 92%, I can only imagine the crap that must be in other companies' R&D. Adjusted EPS is executive code for "we always get 140% bonuses". Goal Weighting Score Composite Score Deliver Revenue Growth 30% 95.0 % 28.5% Deliver Adjusted EPS Growth 30% 202.3 % 60.7% Advance Denosumab 20% 147.6 % 29.5% Deliver the Best Pipeline 15% 92.0 % 13.8% Expand Internationally 5% 131.6 % 6.6% Totals 100% 139.1%
